Overview

Neurobiology of Opioid Dependence: 2 - 2

Status:
Withdrawn
Trial end date:
1998-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Analgesics, Opioid